Form 4: National Healthcare Corp. Executive Vicki L. Dodson Granted Stock Options
SEC Form 4 Filing
Vicki L. Dodson, Sr. VP Patient Services at National Healthcare Corp, reports the grant of stock options.
Summary
- On February 24, 2025, Vicki L. Dodson, Sr. VP Patient Services at National Healthcare Corp (NHC), was granted 13,500 stock options.
- These options, with an exercise price of $90.62, were granted under the 2020 Omnibus Equity Incentive Plan.
- The options vest ratably over three years, starting February 24, 2026, and expire on February 24, 2030.
- Dodson also directly owns 6,600.5455 shares of common stock.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of stock option grants, which is neutral in sentiment. It reflects standard executive compensation practices.
Positives
- The grant of stock options aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The document outlines the vesting schedule for the granted stock options, indicating future dates when the executive can exercise these options.
Industry Context
Stock option grants are a common practice in the healthcare industry to incentivize and retain key executives. The vesting schedule is typical for such grants.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the healthcare industry.
- Companies like Brookdale Senior Living and HCA Healthcare also utilize stock options as part of their executive compensation plans.
- The vesting schedule of three years is a common practice, aligning with industry norms for long-term incentive plans.
Stakeholder Impact
- The stock option grant could potentially increase shareholder value if the executive's performance improves the company's financial results.
- The grant incentivizes the executive, potentially leading to better patient services and improved company performance.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date exercisable for options to purchase 3,734 shares of common stock at $63.96, expiring 02/18/2027 |
| 03/08/2024 | Date exercisable for options to purchase 7,467 shares of common stock at $53.94, expiring 03/08/2028 |
| 03/05/2025 | Date exercisable for options to purchase 12,000 shares of common stock at $94.1, expiring 03/05/2029 |
| 02/24/2025 | Date of stock option grant for 13,500 shares at $90.62, expiring 02/24/2030 |
| 02/24/2026 | First vesting date for one-third of the newly granted stock options. |
| 02/24/2027 | Second vesting date for one-third of the newly granted stock options. |
| 02/24/2028 | Final vesting date for one-third of the newly granted stock options. |
| 02/24/2030 | Expiration date of the newly granted stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.